GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocCheck AG (XTER:AJ91) » Definitions » Operating Income

DocCheck AG (XTER:AJ91) Operating Income : €3.39 Mil (TTM As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is DocCheck AG Operating Income?

DocCheck AG's Operating Income for the six months ended in Jun. 2024 was €2.17 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2024 was €3.39 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. DocCheck AG's Operating Income for the six months ended in Jun. 2024 was €2.17 Mil. DocCheck AG's Revenue for the six months ended in Jun. 2024 was €24.44 Mil. Therefore, DocCheck AG's Operating Margin % for the quarter that ended in Jun. 2024 was 8.86%.

Warning Sign:

DocCheck AG operating margin has been in a 5-year decline. The average rate of decline per year is -8.8%.

DocCheck AG's 5-Year average Growth Rate for Operating Margin % was -8.80% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. DocCheck AG's annualized ROC % for the quarter that ended in Jun. 2024 was 9.45%. DocCheck AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 35.24%.


DocCheck AG Operating Income Historical Data

The historical data trend for DocCheck AG's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocCheck AG Operating Income Chart

DocCheck AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.26 13.35 16.53 8.89 3.10

DocCheck AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.27 4.62 1.88 1.22 2.17

DocCheck AG Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €3.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DocCheck AG  (XTER:AJ91) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

DocCheck AG's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=4.33 * ( 1 - 32.34% )/( (31.706 + 30.292)/ 2 )
=2.929678/30.999
=9.45 %

where

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

DocCheck AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=5.794/( ( (15.827 + max(2.234, 0)) + (14.822 + max(-1.185, 0)) )/ 2 )
=5.794/( ( 18.061 + 14.822 )/ 2 )
=5.794/16.4415
=35.24 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8.086 + 3.155 + 3.084) - (6.915 + 0 + 5.176)
=2.234

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(5.95 + 3.185 + 3.234) - (4.894 + 0 + 8.66)
=-1.185

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. Operating Income is also linked to Operating Margin %:

DocCheck AG's Operating Margin % for the quarter that ended in Jun. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=2.165/24.44
=8.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


DocCheck AG Operating Income Related Terms

Thank you for viewing the detailed overview of DocCheck AG's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


DocCheck AG Business Description

Traded in Other Exchanges
Address
Doccheck AG, Vogelsanger Strac E 66, Koln, DEU, 50823
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
Executives
Dr. Frank Antwerpes Board of Directors

DocCheck AG Headlines

No Headlines